Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Português
March 2, 2026
Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in Japan.
NT
Naoki Takamatsu
HK
Hiroki Kimura
MO
Mari S. Oba
See all
Key Points
To investigate levels of interleukin-1β in individuals recovering from COVID-19.
Conducted a nationwide registry study in Japan
Analyzed interleukin-1β levels in post-COVID-19 patients
Compared levels to pre-infection baselines
Found significantly elevated interleukin-1β levels in post-COVID-19 patients
Indicated chronic inflammation as a potential issue
Results suggest ongoing immune response in affected individuals
Abstract
Japan Registry of Clinical Trials: jRCT1030220711.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in Japan. | Synapse
Cite This Study
Copy
Takamatsu et al. (Sun,) studied this question.
synapsesocial.com/papers/69a52df3f1e85e5c73bf126f
https://doi.org/https://doi.org/10.1002/npr2.70082